Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Vir Biotechnology Inc. has launched and is raising more than $150mm in Series A money. Lead investors were Arch Venture Partners, which itself committed $150mm, and the Bill & Melinda Gates Foundation, as well as sovereign wealth funds, public mutual funds, and individuals and family offices.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?